232 related articles for article (PubMed ID: 29915289)
1. Kcnn4 is a modifier gene of intestinal cystic fibrosis preventing lethality in the Cftr-F508del mouse.
Philp AR; Riquelme TT; Millar-Büchner P; González R; Sepúlveda FV; Cid LP; Flores CA
Sci Rep; 2018 Jun; 8(1):9320. PubMed ID: 29915289
[TBL] [Abstract][Full Text] [Related]
2. Abolition of Ca2+-mediated intestinal anion secretion and increased stool dehydration in mice lacking the intermediate conductance Ca2+-dependent K+ channel Kcnn4.
Flores CA; Melvin JE; Figueroa CD; Sepúlveda FV
J Physiol; 2007 Sep; 583(Pt 2):705-17. PubMed ID: 17584847
[TBL] [Abstract][Full Text] [Related]
3. Potential genetic modifiers of the cystic fibrosis intestinal inflammatory phenotype on mouse chromosomes 1, 9, and 10.
Norkina O; De Lisle RC
BMC Genet; 2005 May; 6():29. PubMed ID: 15921521
[TBL] [Abstract][Full Text] [Related]
4. The K+ channel opener 1-EBIO potentiates residual function of mutant CFTR in rectal biopsies from cystic fibrosis patients.
Roth EK; Hirtz S; Duerr J; Wenning D; Eichler I; Seydewitz HH; Amaral MD; Mall MA
PLoS One; 2011; 6(8):e24445. PubMed ID: 21909392
[TBL] [Abstract][Full Text] [Related]
5. Defective regulatory volume decrease in human cystic fibrosis tracheal cells because of altered regulation of intermediate conductance Ca2+-dependent potassium channels.
Vázquez E; Nobles M; Valverde MA
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5329-34. PubMed ID: 11309505
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.
Schippa S; Iebba V; Santangelo F; Gagliardi A; De Biase RV; Stamato A; Bertasi S; Lucarelli M; Conte MP; Quattrucci S
PLoS One; 2013; 8(4):e61176. PubMed ID: 23613805
[TBL] [Abstract][Full Text] [Related]
7. Two Small Molecules Restore Stability to a Subpopulation of the Cystic Fibrosis Transmembrane Conductance Regulator with the Predominant Disease-causing Mutation.
Meng X; Wang Y; Wang X; Wrennall JA; Rimington TL; Li H; Cai Z; Ford RC; Sheppard DN
J Biol Chem; 2017 Mar; 292(9):3706-3719. PubMed ID: 28087700
[TBL] [Abstract][Full Text] [Related]
8. Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation.
De Stefano D; Villella VR; Esposito S; Tosco A; Sepe A; De Gregorio F; Salvadori L; Grassia R; Leone CA; De Rosa G; Maiuri MC; Pettoello-Mantovani M; Guido S; Bossi A; Zolin A; Venerando A; Pinna LA; Mehta A; Bona G; Kroemer G; Maiuri L; Raia V
Autophagy; 2014; 10(11):2053-74. PubMed ID: 25350163
[TBL] [Abstract][Full Text] [Related]
9. Correction of chloride transport and mislocalization of CFTR protein by vardenafil in the gastrointestinal tract of cystic fibrosis mice.
Dhooghe B; Noël S; Bouzin C; Behets-Wydemans G; Leal T
PLoS One; 2013; 8(10):e77314. PubMed ID: 24204804
[TBL] [Abstract][Full Text] [Related]
10. An association study on contrasting cystic fibrosis endophenotypes recognizes KRT8 but not KRT18 as a modifier of cystic fibrosis disease severity and CFTR mediated residual chloride secretion.
Stanke F; Hedtfeld S; Becker T; Tümmler B
BMC Med Genet; 2011 May; 12():62. PubMed ID: 21548936
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological Correction of Cystic Fibrosis: Molecular Mechanisms at the Plasma Membrane to Augment Mutant CFTR Function.
Arora K; Naren AP
Curr Drug Targets; 2016; 17(11):1275-81. PubMed ID: 26648081
[TBL] [Abstract][Full Text] [Related]
12. Structural mechanisms for defective CFTR gating caused by the Q1412X mutation, a severe Class VI pathogenic mutation in cystic fibrosis.
Yeh JT; Yu YC; Hwang TC
J Physiol; 2019 Jan; 597(2):543-560. PubMed ID: 30408177
[TBL] [Abstract][Full Text] [Related]
13. Genetic Inhibition Of The Ubiquitin Ligase Rnf5 Attenuates Phenotypes Associated To F508del Cystic Fibrosis Mutation.
Tomati V; Sondo E; Armirotti A; Caci E; Pesce E; Marini M; Gianotti A; Jeon YJ; Cilli M; Pistorio A; Mastracci L; Ravazzolo R; Scholte B; Ronai Z; Galietta LJ; Pedemonte N
Sci Rep; 2015 Jul; 5():12138. PubMed ID: 26183966
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis.
Magalhães M; Rivals I; Claustres M; Varilh J; Thomasset M; Bergougnoux A; Mely L; Leroy S; Corvol H; Guillot L; Murris M; Beyne E; Caimmi D; Vachier I; Chiron R; De Sario A
Clin Epigenetics; 2017; 9():19. PubMed ID: 28289476
[TBL] [Abstract][Full Text] [Related]
15. Mucosal potassium efflux mediated via Kcnn4 channels provides the driving force for electrogenic anion secretion in colon.
Nanda Kumar NS; Singh SK; Rajendran VM
Am J Physiol Gastrointest Liver Physiol; 2010 Sep; 299(3):G707-14. PubMed ID: 20616305
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of Tis7/IFRD1 protein in murine and human cystic fibrosis airway epithelial cell models homozygous for the F508del-CFTR mutation.
Blanchard E; Marie S; Riffault L; Bonora M; Tabary O; Clement A; Jacquot J
Biochem Biophys Res Commun; 2011 Aug; 411(3):471-6. PubMed ID: 21723850
[TBL] [Abstract][Full Text] [Related]
17. Mast cells and gastrointestinal dysmotility in the cystic fibrosis mouse.
De Lisle RC; Meldi L; Roach E; Flynn M; Sewell R
PLoS One; 2009; 4(1):e4283. PubMed ID: 19172182
[TBL] [Abstract][Full Text] [Related]
18. Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epithelia.
Stanke F; Becker T; Kumar V; Hedtfeld S; Becker C; Cuppens H; Tamm S; Yarden J; Laabs U; Siebert B; Fernandez L; Macek M; Radojkovic D; Ballmann M; Greipel J; Cassiman JJ; Wienker TF; Tümmler B
J Med Genet; 2011 Jan; 48(1):24-31. PubMed ID: 20837493
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-13 (IL-13)/IL-13 receptor alpha1 (IL-13Ralpha1) signaling regulates intestinal epithelial cystic fibrosis transmembrane conductance regulator channel-dependent Cl- secretion.
Wu D; Ahrens R; Osterfeld H; Noah TK; Groschwitz K; Foster PS; Steinbrecher KA; Rothenberg ME; Shroyer NF; Matthaei KI; Finkelman FD; Hogan SP
J Biol Chem; 2011 Apr; 286(15):13357-69. PubMed ID: 21303908
[TBL] [Abstract][Full Text] [Related]
20. ORKAMBI-Mediated Rescue of Mucociliary Clearance in Cystic Fibrosis Primary Respiratory Cultures Is Enhanced by Arginine Uptake, Arginase Inhibition, and Promotion of Nitric Oxide Signaling to the Cystic Fibrosis Transmembrane Conductance Regulator Channel.
Wu YS; Jiang J; Ahmadi S; Lew A; Laselva O; Xia S; Bartlett C; Ip W; Wellhauser L; Ouyang H; Gonska T; Moraes TJ; Bear CE
Mol Pharmacol; 2019 Oct; 96(4):515-525. PubMed ID: 31427400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
